Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
188,793,708
-
Shares change
-
-2,627,971
-
Total reported value, excl. options
-
$205,786,015
-
Value change
-
-$5,677,228
-
Put/Call ratio
-
302%
-
Number of buys
-
51
-
Number of sells
-
-51
-
Price
-
$1.09
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2023
135 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2023.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 188,793,708 shares
of 363,214,619 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include Artal Group S.A. (117,553,284 shares), BVF INC/IL (19,995,332 shares), FMR LLC (7,563,076 shares), BlackRock Inc. (6,654,966 shares), VANGUARD GROUP INC (6,400,211 shares), MILLENNIUM MANAGEMENT LLC (3,885,753 shares), JPMORGAN CHASE & CO (2,815,034 shares), NEA Management Company, LLC (2,382,286 shares), GEODE CAPITAL MANAGEMENT, LLC (2,126,137 shares), and Octagon Capital Advisors LP (1,923,076 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.